Weill Cornell Medicine, Department of Cardiothoracic Surgery, New York, NY, United States.
Weill Cornell Medicine, Department of Cardiology, New York, NY, United States.
Int J Surg. 2017 Aug;44:132-138. doi: 10.1016/j.ijsu.2017.06.046. Epub 2017 Jun 20.
Triple valve surgery (TVS) remains a challenging procedure with limited existing literature. We aim to evaluate the prevalence, in-hospital outcomes, and prognostic determinants of TVS in the current era.
We reviewed the Nationwide Inpatient Sample database from 2003 to 2012 and included all patients who underwent aortic valve replacement (AVR) combined with mitral valve replacement (MVR) or repair (MVRep) and tricuspid valve replacement (TVR) or repair (TVRep). Logistic regression analysis was used to identify independent predictors of in-hospital mortality and propensity score matching was adopted to compare groups receiving different operations.
Overall, 5234 patients were included. In-hospital mortality was 13.9%. Major adverse events occurred in 42.9% of the cases (44.9%, 40.3%, 44.4% and 74.2% in the AVR + MVR + TVR, AVR + MVR + TVRep, AVR + MVRep + TVRep and AVR + MVRep + TVR groups respectively, p < 0.05 for all intergroup comparisons). In-hospital mortality in the AVR + MVR + TVR, AVR + MVR + TVRep, AVR + MVRep + TVRep and AVR + MVRep + TVR groups was 19.9%, 13.3%, 12.9% and 0% respectively (p < 0.05 for all intergroup comparisons). At regression analysis, age, reoperation, and urgent/emergent operation were independent predictors of in-hospital mortality. Patients submitted to tricuspid valve repair and mitral and tricuspid repair had a 62% and 63% mortality risk reduction (OR:0.380, CI:0.19-0.76 p = 0.006 and OR:0.37, CI:0.18-0.78 p = 0.009 respectively). In the propensity matched comparisons, in-hospital mortality was statistically similar (p = 0.08 for AVR + MVR + TVR vs. AVR + MVR + TVRep comparison and p = 0.06 for AVR + MVR + TVR vs. AVR + MVRep + TVRep comparison).
TVS is associated with significant in-hospital mortality and morbidity. The use of valve repair strategies for the mitral and tricuspid valves can positively impact postoperative outcomes.
三尖瓣手术(TVS)仍然是一项具有挑战性的手术,相关文献有限。我们旨在评估当前时代 TVS 的流行率、住院期间的结果和预后决定因素。
我们回顾了 2003 年至 2012 年的全国住院患者样本数据库,并纳入了所有接受主动脉瓣置换术(AVR)联合二尖瓣置换术(MVR)或修复术(MVRep)和三尖瓣置换术(TVR)或修复术(TVRep)的患者。采用逻辑回归分析确定住院死亡率的独立预测因素,并采用倾向评分匹配比较接受不同手术的患者。
总体而言,纳入了 5234 名患者。住院死亡率为 13.9%。42.9%的病例发生重大不良事件(AVR+MVR+TVR、AVR+MVR+TVRep、AVR+MVRep+TVRep 和 AVR+MVRep+TVR 组分别为 44.9%、40.3%、44.4%和 74.2%,p<0.05 用于所有组间比较)。AVR+MVR+TVR、AVR+MVR+TVRep、AVR+MVRep+TVRep 和 AVR+MVRep+TVR 组的住院死亡率分别为 19.9%、13.3%、12.9%和 0%(p<0.05 用于所有组间比较)。在回归分析中,年龄、再次手术和紧急/急诊手术是住院死亡率的独立预测因素。接受三尖瓣修复和二尖瓣及三尖瓣修复的患者死亡率降低了 62%和 63%(OR:0.380,CI:0.19-0.76,p=0.006 和 OR:0.37,CI:0.18-0.78,p=0.009)。在倾向匹配的比较中,住院死亡率无统计学差异(AVR+MVR+TVR 与 AVR+MVR+TVRep 比较 p=0.08,AVR+MVR+TVR 与 AVR+MVRep+TVRep 比较 p=0.06)。
TVS 与显著的住院死亡率和发病率相关。二尖瓣和三尖瓣瓣膜修复策略的应用可以对术后结果产生积极影响。